Particle therapy: Carbon ions;L'hadronthérapie: Les ions carbone

Bulletin du Cancer

Volumn 97, Issue 7, 2010, Pages 819-829

  Pommier, Pascal ^a,b   Hu, Yi ^c   Baron, Marie Hélène ^d   Chapet, Olivier ^e   Balosso, Jacques ^b,f  

^a CENTRE LÉON BÉRARD   (France)

^b GCS ETOILE   (France)

^c LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^d UNIVERSITY HOSPITAL OF BESANÇON   (France)

^e UNIVERSITÉ LYON 1   (France)

^f GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Carbon ions; Light ions beams; Radiation oncology; Radioresistance

Indexed keywords

CANCER RADIOTHERAPY; CELL KILLING; CYCLOTRON; DOSIMETRY; HADRON; HADRON THERAPY; HUMAN; ION THERAPY; RADIATION BEAM; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; REVIEW; SYNCHROTRON; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 77955641880     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2010.1151     Document Type: Review

References (50)

1. Jones B. The case for particle therapy. British J Radiology 2006; 79: 24-31.
2. Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 2007; 25: 953-64. (Pubitemid 350002861)
3. Schulz-Ertner D, Jäkel O, Schlegel W. Radiation therapy with charged particles. Semin Radiat Oncol 2006; 16: 249-59.
4. Fokas E, Kraft G, An H, Engenhart-Cabillic R. Ion beam radiobiology and cancer: time to update ourselves. Biochim Biophys Acta 2009; 1796: 216-29.
5. Inaniwa T, Kohno T, Tomitani T, Sato S. Monitoring the irradiation field of 12C and 16O SOBP beams using positron emitters produced through projectile fragmentation reactions. Phys Med Biol 2008; 53: 529-42.
6. Baron MH, Pommier P, Favrel V, Truc G, Balosso J, Rochat JA. "one-day survey": as a reliable estimation of the potential recruitment for proton- and carbon- ion therapy in France. Radiother Oncol 2004; 73: S15-7.
7. Mayer R, Mock U, Jäger R, Pötter R, Vutuc C, Eiter H, et al. Epidemiological aspects of hadron therapy: a prospective nationwide study of the Austrian project MedAustron and the Austrian Society of Radiooncology (OEGRO). Radiother Oncol 2004; 73: S24-8.
8. Jäkel O, Land B, Combs SE, Schulz-Ertner D, Debus J. On the cost-effectiveness of Carbon ion radiation therapy for skull base chordoma. Radiother Oncol 2007; 83: 133-8. (Pubitemid 46776917)
9. Laramore, et al. Neutron versus photon irradiation for unresectable salivary gland tumors: Final report of an RTOG-MRC randomized clinical trial. Int J Radiation Oncology Biol Phys 1993; 27: 235-40.
10. Chen, et al. Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas. Int J Radiation Oncology Biol Phys 2006; 66: 1044-55.
11. Terhaard, et al. The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiation Oncology Biol Phys 2005; 61: 103-11.
12. Mizoe, et al. PTCOG 46 Educational workshop Session IV: Clinical Head & Neck. 2007.
13. Duthoy, et al. Postoperative intensity-modulated radiotherapy in sinonasal carcinoma. Cancer 2005; 104: 71-82.
14. Daly, et al. Intensity-modulated radiationtherapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiation Oncology Biol Phys 2007; 67: 151-7.
15. Dirix, et al. Post-operative intensity-moduated radiotherapy for malignancies of the nasal cavity and paranasal sinuses. Radiotherapy and Oncology 2007; 85: 385-91.
16. Madani, et al. Long-term radiotherapy outcomes or nasal cavity and septal cancers. Int J Radiation Oncology Biol Phys 2009; 73: 424-32.
17. Schulz-Ertner, et al. Results of carbon ion radiotherapy in 152 patients. Int J Radiation Oncology Biol Phys 2004; 58: 631-40.
18. Bittner, et al. Treatment of locally advanced adenoid cystic carcinoma of the trachea with neutron radiotherapy. Int J Radiation Oncology Biol Phys 2008; 72: 410-4.
19. Douglas, et al. Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy. Int J Radiation Oncology Biol Phys 2000; 46: 551-7.
20. Prott, et al. Results of fast neutron therapy of adenoid cystic carcinoma of the salivary glands. Anticancer Research 2000; 20: 3743-50.
21. Brackrock, et al. Neutron therapy, prognostic factors and dedifferentiation of adenoid cystic carcinomas (ACC) of salivary glands. Anticancer Research 2006; 25: 1321-6.
22. Pommier, et al. Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg 2006; 132: 1242-9.
23. Wada, et al. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in northern Japan. Int J Radiation Oncology Biol Phys 2004; 59: 495-500.
24. Gilligan, et al. Radical radiotherapy for 28 cases mucosal melanoma in the nasal cavity and sinuses. Br J Radiol 1991; 64: 1147-50.
25. Tsunemoto, et al. Characteristics of malignant melanoma cells in the treatment with fast neutrons. Pigment Cell Res 1989; 2: 372-8.
26. Proceedings of NIRS-CNAO Joint symposium on carbon ion radiotherapy, November 2006.
27. Weber D, et al. Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: The paul scherrer institut experience. Int J Radiation Oncology Biol Phys 2005; 63: 401-9.
28. Noel G, et al. Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams. Acta Oncologica 2005; 44: 700-8.
29. Noel, et al. Radiotherapeutic factors in the management of cervical-basal chordomas and chondrosarcomas. Neurosurgery 2004; 55: 1252-62.
30. Munzenrider JE, et al. Proton therapy for tumors of the skull base. Strahlenther Onkol 1999; 175 (Suppl 2): 57-63. (Pubitemid 29533454)
31. Hug MD, et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 1999; 91: 432-9.
32. Schulz-Ertner MD, et al. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiation Oncology Biol Phys 2007; 68: 449-57.
33. Schulz-Ertner MD, et al. Carbon ion radiotherapy of skull-base chondrosarcomas. Int J Radiation Oncology Biol Phys 2007; 67: 171-7.
34. Breteau N, et al. Sacrococcygeal chordomas: potential role of high LET therapy. Recent Results Cancer Res 1998; 150: 148-55.
35. Park, et al. Sacral chordomas: impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiation Oncology Biol Phys 2006; 65: 1514-21.
36. Imai MD, et al. Carbon ion radiotherapy for unresectable sacral chordomas. Clinical Cancer Research 2004; 10: 5741-6.
37. Kim, et al. Clinical significance of margin status in postoperative radiotherapy for extremity and truncal soft-tissue sarcoma. Int J Radiation Oncology Biol Phys 2008; 70: 139-44.
38. Zagars GK, et al. Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy. Cancer 2003; 97: 2544-53.
39. Zagars GK, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer 2003; 97: 2544-53.
40. Alektiar, et al. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity. Int J Radiation Oncology Biol Phys 2005; 63: 202-8.
41. Stoeckle, et al. Prospective evaluation of quality of surgery in soft tissue sarcoma. EJOS 2006; 32: 1242-8.
42. Schwartz, et al. Fast neutron radiotherapy for soft tissue and cartilaginous sarcomas at high risk for local recurrence. Int J Radiation Oncology Biol Phys 2001; 50: 449-65.
43. Schmitt, et al. The role of neutrons in the treatment of soft tissue sarcomas. Cancer 1989; 64: 2064-8.
44. Kepka, et al. Results of radiation therapy for unresected soft-tissue sarcomas. Int J Radiation Oncology Biol Phys 2005; 63: 852-9.
45. Weber, et al. Spot scanning proton therapy in the curative treatment of adult patients with sarcoma: the Paul Scherrer institute experience. Int J Radiation Oncology Biol Phys 2007; 69: 865-71.
46. Kamada T, Tsujii H, Tsuji H, Yanagi T, Mizoe J-E, Miyamoto T, et al. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol 2002; 20: 4461-71.
47. Serizawa I, Kagei K, Kamada T, Imai R, Sugahara S, Okada T, et al. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys 2009; 75: 1105-10.
48. Krämer M, Jäkel O, Haberer T, Rietzel E, Schardt D, Scholz M, et al. Treatment planning for scanned ion beams. Radiother Oncol 2004; 73: S80-5.
49. Mazal A, Habrand JL, Delacroix S, Datchary J, Dendale R, Desjardins L, et al. La protonthérapie: bases, indications et nouvelles technologies. Bull Cancer 2010, vol 97 (in press).
50. Suit H, DeLaney T, Goldberg et al. Proton vs. carbon ion beams in the definitive treatment of cancer patients. Radiother Oncol 2010; 3-22.